Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Immunological Reviews|October 14, 2017
Danger signals: Chemotherapy enhancers?Thaiz Rivera Vargas, Lionel ApetohFrontiers in Immunology|June 14, 2019
Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?Thaiz Rivera Vargas, Lionel ApetohEuropean Journal of Cancer (Oxford, England : 1990)|February 21, 2017
Rationale for stimulator of interferon genes-targeted cancer immunotherapyThaiz Rivera Vargas, Isis Benoit-Lizon, Lionel ApetohCells|July 26, 2020
Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint InhibitorsMagalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas, et al.Seminars in Immunopathology|November 11, 2016
TH9 cells in anti-tumor immunityThaiz Rivera Vargas, Etienne Humblin, Frédérique Végran, et al.Current Opinion in Pharmacology|May 29, 2017
Immunotherapeutic properties of chemotherapyCarole Fournier, Thaiz Rivera Vargas, Tiffany Martin, et al.Nature Communications|September 17, 2017
Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cellsThaiz Rivera Vargas, Zhijian Cai, Yingying Shen, et al.British Journal of Cancer|July 7, 2020
Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cellsLionel ApetohWorld Journal of Biological Chemistry|March 7, 2014
Role of 3'-untranslated region translational control in cancer development, diagnostics and treatmentAndrii Vislovukh, Thaiz Rivera Vargas, Anna Polesskaya, et al.Biomedical Journal|August 29, 2014
Enhancing the anticancer effects of 5-fluorouracil: current challenges and future perspectivesFrancois Ghiringhelli, Lionel ApetohPageof 12